Vistin Pharma ASA (OSL:VISTN)
Norway flag Norway · Delayed Price · Currency is NOK
24.40
+0.30 (1.24%)
At close: Aug 15, 2025

Vistin Pharma ASA Revenue

Vistin Pharma ASA had revenue of 117.67M NOK in the quarter ending June 30, 2025, with 10.92% growth. This brings the company's revenue in the last twelve months to 452.25M, up 2.64% year-over-year. In the year 2024, Vistin Pharma ASA had annual revenue of 429.50M, down -2.01%.

Revenue (ttm)
452.25M
Revenue Growth
+2.64%
P/S Ratio
2.39
Revenue / Employee
6.20M
Employees
75
Market Cap
1.08B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024429.50M-8.83M-2.01%
Dec 31, 2023438.33M133.48M43.78%
Dec 31, 2022304.85M26.23M9.41%
Dec 31, 2021278.62M24.72M9.73%
Dec 31, 2020253.91M25.78M11.30%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medistim ASA 603.92M
Nordhealth AS 545.88M
Photocure ASA 522.86M
Omda AS 442.14M
ArcticZymes Technologies ASA 102.97M
Gentian Diagnostics ASA 163.38M
Lytix Biopharma AS 608.00K
Nykode Therapeutics AS 87.09M
Revenue Rankings